Back
Surgery Partners Stock Price Chart
Sponsored
SGRY
Sponsored
NEW: AI Breakthrough to Send Economy Skyrocketing by $200 Trillion?
And with the one move I detail here, you can secure a share of this 10,000% boom.
Buy
57
SGRY
Surgery Partners
Last Price:
29.79
Seasonality Move:
10.09%
7 Day Trial
ALL ACCESS PASS
$
7
$200 Trillion "AI Phase 2" Moments Away?
And if you click here now, you'll see how YOU could get a piece of the action...- The current trend is relatively stagnant and SGRY is experiencing buying pressure, which is a positive indicator for future bullish movement.
Surgery Partners Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.39 | Buy |
20-day SMA: | 29.3 | Buy |
50-day SMA: | 31.16 | Sell |
200-day SMA: | 32.79 | Sell |
8-day EMA: | 28.87 | Buy |
20-day EMA: | 29.42 | Buy |
50-day EMA: | 30.52 | Sell |
200-day EMA: | 31.94 | Sell |
Surgery Partners Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.78 | Sell |
Relative Strength Index (14 RSI): | 50.95 | Buy |
Chaikin Money Flow: | 452501 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.3 - 31.3) | Buy |
Bollinger Bands (100): | (28.98 - 33.6) | Sell |
Surgery Partners Technical Analysis
Mar 14 | Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Surgery Partners Stock
Is Surgery Partners Stock a Buy?
- Surgery Partners share price is 29.94 while SGRY 8-day simple moving average is 28.39, which is a Buy signal.
- The stock price of SGRY is 29.94 while Surgery Partners 20-day SMA is 29.30, which makes it a Buy.
- Surgery Partners 50-day simple moving average is 31.16 while SGRY share price is 29.94, making it a Sell technically.
- SGRY stock price is 29.94 and Surgery Partners 200-day simple moving average is 32.79, creating a Sell signal.
SGRY Technical Analysis vs Fundamental Analysis
Buy
57
Surgery Partners (SGRY)
is a Buy
Is Surgery Partners a Buy or a Sell?
-
Surgery Partners stock is rated a Buy
The current Surgery Partners [SGRY] share price is $29.94. The Score for SGRY is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Surgery Partners Stock Info
Market Cap:
3.79B
Price in USD:
29.94
Share Volume:
782.54K
Surgery Partners 52-Week Range
52-Week High:
45.79
52-Week Low:
22.05
Buy
57
Surgery Partners (SGRY)
is a Buy
Surgery Partners Share Price Forecast
-
What is the Surgery Partners stock price today?
The Surgery Partners stock price is 29.94 USD today. -
Will SGRY stock go up or go down?
Surgery Partners> share price is forecast to RISE/FALL based on technical indicators -
Is Surgery Partners overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Surgery Partners is not overvalued.
Is Surgery Partners Stock a Buy?
- Surgery Partners share price is 29.94 while SGRY 8-day exponential moving average is 28.87, which is a Buy signal.
- The stock price of SGRY is 29.94 while Surgery Partners 20-day EMA is 29.42, which makes it a Buy.
- Surgery Partners 50-day exponential moving average is 30.52 while SGRY share price is 29.94, making it a Sell technically.
- SGRY stock price is 29.94 and Surgery Partners 200-day simple moving average is 31.94, creating a Sell signal.
Fundamental Analysis of Surgery Partners
Is Surgery Partners a good investment?
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.10 per share, an increase this year of $0.11 per share, and an increase next year of $0.25 per share.
Technical Analysis of Surgery Partners
Should I short Surgery Partners stock?
- SGRY Moving Average Covergence Divergence (MACD) indicator is -0.78, suggesting Surgery Partners is a Sell
- Surgery Partners Relative Strength Index (RSI) is 50.95, which suggest Surgery Partners is overbought
- The Bollinger Bands (25) for Surgery Partners is (28.3 - 31.3), which suggest Surgery Partners is a Sell
- The Bollinger Bands (100) for Surgery Partners is (28.98 - 33.6), which suggest Surgery Partners is a Sell
* Surgery Partners stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.